In Vitro Activities of ER-119884 and E5700, Two Potent Squalene Synthase Inhibitors, against
Leishmania amazonensis
: Antiproliferative, Biochemical, and Ultrastructural Effects
-
Published:2008-11
Issue:11
Volume:52
Page:4098-4114
-
ISSN:0066-4804
-
Container-title:Antimicrobial Agents and Chemotherapy
-
language:en
-
Short-container-title:Antimicrob Agents Chemother
Author:
Fernandes Rodrigues Juliany Cola1, Concepcion Juan Luis2, Rodrigues Carlos3, Caldera Aura3, Urbina Julio A.3, de Souza Wanderley1
Affiliation:
1. Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, CCS, Bloco G, subsolo, Ilha do Fundão, Rio de Janeiro, RJ 21.941-902, Brazil 2. Laboratorio de Enzimologia de Parasitos, Facultad de Ciencias, Universidad de los Andes, Merida, Venezuela 3. Laboratório de Química Biológica, Centro de Bioquímica y Biofísica, Instituto Venezolano de Investigaciones Científicas, Apartado 21827, Caracas 1020A, Venezuela
Abstract
ABSTRACT
ER-119884 and E5700, novel arylquinuclidine derivatives developed as cholesterol-lowering agents, were potent in vitro growth inhibitors of both proliferative stages of
Leishmania amazonensis
, the main causative agent of cutaneous leishmaniasis in South America, with the 50% inhibitory concentrations (IC
50
s) being in the low-nanomolar to subnanomolar range. The compounds were very potent noncompetitive inhibitors of native
L. amazonensis
squalene synthase (SQS), with inhibition constants also being in the nanomolar to subnanomolar range. Growth inhibition was strictly associated with the depletion of the parasite's main endogenous sterols and the concomitant accumulation of exogenous cholesterol. Using electron microscopy, we identified the intracellular structures affected by the compounds. A large number of lipid inclusions displaying different shapes and electron densities were observed after treatment with both SQS inhibitors, and these inclusions were associated with an intense disorganization of the membrane that surrounds the cell body and flagellum, as well as the endoplasmic reticulum and the Golgi complex. Cells treated with ER-119884 but not those treated with E5700 had an altered cytoskeleton organization due to an abnormal distribution of tubulin, and many were arrested at cytokinesis. A prominent contractile vacuole and a phenotype typical of programmed cell death were frequently found in drug-treated cells. The selectivity of the drugs was demonstrated with the JC-1 mitochondrial fluorescent label and by trypan blue exclusion tests with macrophages, which showed that the IC
50
s against the host cells were 4 to 5 orders of magnitude greater that those against the intracellular parasites. Taken together, our results show that ER-119884 and E5700 are unusually potent and selective inhibitors of the growth of
Leishmania amazonensis
, probably because of their inhibitory effects on de novo sterol biosynthesis at the level of SQS, but some of our observations indicate that ER-119884 may also interfere with other cellular processes.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference55 articles.
1. Barral, A., D. Pedral-Sampaio, G. Grimaldi, Jr., H. Momen, D. McMahon-Pratt, A. R. de Jesus, R. Almeida, R. Badaró, M. Barral, and E. M. Carvalho. 1991. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg.44:536-546. 2. Barrett-Bee, K., and N. Ryder. 1992. Biochemical aspects of ergosterol biosynthesis inhibition, p. 437-475. In J. Sutcliffe, and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman & Hall, New York, NY. 3. Berman, J. 2005. Recent developments in leishmaniasis: epidemiology, diagnosis, and treatment. Curr. Infect. Dis. Rep.7:33-38. 4. Braga, M. V., J. A. Urbina, and W. de Souza. 2004. Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi. Int. J. Antimicrob. Agents24:72-78. 5. Brown, G. R., D. S. Clarke, A. J. Foubister, S. Freeman, P. J. Harrison, M. C. Johnson, K. B. Mallion, J. McCormick, F. McTaggart, A. C. Reid, G. J. Smith, and M. J. Taylor. 1996. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors. J. Med. Chem.39:2971-2979.
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|